132 related articles for article (PubMed ID: 14972750)
1. Use of a simple fractionation method to evaluate binding, internalization and intracellular distribution of oligonucleotides in vascular smooth muscle cells.
Eboue D; Auger R; Angiari C; Le Doan T; Tenu JP
Arch Physiol Biochem; 2003 Jul; 111(3):265-72. PubMed ID: 14972750
[TBL] [Abstract][Full Text] [Related]
2. Sequence dependency of the internalization and distribution of phosphorothioate oligonucleotides in vascular smooth muscle cells.
Etore F; Tenu JP; Teiger E; Adnot S; Lonchampt MO; Pirotzki E; Le Doan T
Biochem Pharmacol; 1998 May; 55(9):1465-73. PubMed ID: 10076539
[TBL] [Abstract][Full Text] [Related]
3. Polyethylenimine but not cationic lipid improves antisense activity of 3'-capped phosphodiester oligonucleotides.
Dheur S; Dias N; van Aerschot A; Herdewijn P; Bettinger T; Rémy JS; Hélène C; Saison-Behmoaras ET
Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):515-25. PubMed ID: 10645777
[TBL] [Abstract][Full Text] [Related]
4. [A simple method for the study of cytosolic content of oligonucleotides in cells].
Tenu JP; Etoré F; Le Doan T
C R Acad Sci III; 1997 Jun; 320(6):477-86. PubMed ID: 9247027
[TBL] [Abstract][Full Text] [Related]
5. Sustained release of nanosized complexes of polyethylenimine and anti-TGF-beta 2 oligonucleotide improves the outcome of glaucoma surgery.
Gomes dos Santos AL; Bochot A; Doyle A; Tsapis N; Siepmann J; Siepmann F; Schmaler J; Besnard M; Behar-Cohen F; Fattal E
J Control Release; 2006 May; 112(3):369-81. PubMed ID: 16644054
[TBL] [Abstract][Full Text] [Related]
6. Absolute bioavailability of 2'-O-(2-methoxyethyl)-modified antisense oligonucleotides following intraduodenal instillation in rats.
Geary RS; Khatsenko O; Bunker K; Crooke R; Moore M; Burckin T; Truong L; Sasmor H; Levin AA
J Pharmacol Exp Ther; 2001 Mar; 296(3):898-904. PubMed ID: 11181922
[TBL] [Abstract][Full Text] [Related]
7. Interactions of phosphodiester and phosphorothioate oligonucleotides with intestinal epithelial Caco-2 cells.
Beck GF; Irwin WJ; Nicklin PL; Akhtar S
Pharm Res; 1996 Jul; 13(7):1028-37. PubMed ID: 8842040
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence microscopic comparison of the binding of phosphodiester and phosphorothioate (antisense) oligodeoxyribonucleotides to subcellular structures, including intermediate filaments, the endoplasmic reticulum, and the nuclear interior.
Shoeman RL; Hartig R; Huang Y; Grüb S; Traub P
Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):291-308. PubMed ID: 9303181
[TBL] [Abstract][Full Text] [Related]
9. Subcellular trafficking of antisense oligonucleotides and down-regulation of bcl-2 gene expression in human melanoma cells using a fusogenic liposome delivery system.
Hu Q; Bally MB; Madden TD
Nucleic Acids Res; 2002 Aug; 30(16):3632-41. PubMed ID: 12177306
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and blood-brain barrier transport of [3H]-biotinylated phosphorothioate oligodeoxynucleotide conjugated to a vector-mediated drug delivery system.
Wu D; Boado RJ; Pardridge WM
J Pharmacol Exp Ther; 1996 Jan; 276(1):206-11. PubMed ID: 8558431
[TBL] [Abstract][Full Text] [Related]
11. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
[TBL] [Abstract][Full Text] [Related]
12. Altered organ accumulation of oligonucleotides using polyethyleneimine grafted with poly(ethylene oxide) or pluronic as carriers.
Ochietti B; Guérin N; Vinogradov SV; St-Pierre Y; Lemieux P; Kabanov AV; Alakhov VY
J Drug Target; 2002 Mar; 10(2):113-21. PubMed ID: 12074538
[TBL] [Abstract][Full Text] [Related]
13. Cytosolic and nuclear delivery of oligonucleotides mediated by an amphiphilic anionic peptide.
Pichon C; Freulon I; Midoux P; Mayer R; Monsigny M; Roche AC
Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):335-43. PubMed ID: 9303185
[TBL] [Abstract][Full Text] [Related]
14. Oligonucleotide biological activity: relationship to the cell cycle and nuclear transport.
Wu-Pong S; Bard J; Huffman J; Jimerson J
Biol Cell; 1997 Jul; 89(4):257-61. PubMed ID: 9447700
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic properties of 2'-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats.
Geary RS; Watanabe TA; Truong L; Freier S; Lesnik EA; Sioufi NB; Sasmor H; Manoharan M; Levin AA
J Pharmacol Exp Ther; 2001 Mar; 296(3):890-7. PubMed ID: 11181921
[TBL] [Abstract][Full Text] [Related]
16. Antisense oligodeoxynucleotide complementary to platelet-derived growth factor A-chain messenger RNA inhibits the arterial proliferation in spontaneously hypertensive rats without altering their blood pressures.
Fukuda N; Kubo A; Watanabe Y; Nakayama T; Soma M; Izumi Y; Kanmatsuse K
J Hypertens; 1997 Oct; 15(10):1123-36. PubMed ID: 9350586
[TBL] [Abstract][Full Text] [Related]
17. Intracellular localization of oligonucleotides: influence of fixative protocols.
Pichon C; Monsigny M; Roche AC
Antisense Nucleic Acid Drug Dev; 1999 Feb; 9(1):89-93. PubMed ID: 10192293
[TBL] [Abstract][Full Text] [Related]
18. Comparison of binding of N3'-->P5' phosphoramidate and phosphorothioate oligonucleotides to cell surface proteins of cultured cells.
Hawley P; Nelson JS; Fearon KL; Zon G; Gibson I
Antisense Nucleic Acid Drug Dev; 1999 Feb; 9(1):61-9. PubMed ID: 10192290
[TBL] [Abstract][Full Text] [Related]
19. VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
Normand N; Valamanesh F; Savoldelli M; Mascarelli F; BenEzra D; Courtois Y; Behar-Cohen F
Mol Vis; 2005 Mar; 11():184-91. PubMed ID: 15761390
[TBL] [Abstract][Full Text] [Related]
20. Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids.
Zelphati O; Szoka FC
Pharm Res; 1996 Sep; 13(9):1367-72. PubMed ID: 8893276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
